Posaconazole Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Posaconazole Injection (injection) from Merck Sharp & Dohme Corp. with status To Be Discontinued. The shortage was first posted on 12/02/2025.
Shortage Details
- Status
- To Be Discontinued
- Company
- Merck Sharp & Dohme Corp.
- Package NDC
- 0085-4331-01
- Dosage Form
- Injection
- Presentation
- Noxafil, Injection, 18 mg/1 mL (NDC 0085-4331-01)
- Initial Posting
- 12/02/2025
- Revised Date